Biotech

All Articles

Lykos will talk to FDA to reexamine its own decision observing denial of MDMA therapy for post-traumatic stress disorder

.Adhering to a bad revealing for Lykos Rehabs' MDMA prospect for post-traumatic stress disorder at a...

AN 2 fifty percents headcount, ceases period 3 test after information dissatisfy

.AN2 Therapeutics is actually rethinking its service in feedback to dull midphase information, pledg...

Merck pays $700M for bispecific, snooping autoimmune opening and also opportunity to test Amgen in cancer cells

.Merck &amp Co. is actually paying for $700 million ahead of time to test Amgen in a blood cancer ma...

Gilead pays J&ampJ $320M to exit licensing offer for seladelpar

.Along With Gilead Sciences almost an FDA choice for its own liver disease medicine seladelpar, the ...

' All palms on deck' at Lilly as peers target being overweight market

.Chief executive officer David Ricks may observe the firms setting up outdoors tents at basecamp beh...

Entero giving up workers, leaving office and also stopping R&ampD

.Cushion Liquidators has actually switched Entero Therapies white colored as a piece. The lender got...

Exelixis drops ADC after choosing it's no match for Tivdak

.Exelixis is actually surrendering on its tissue element (TF)- targeting antibody-drug conjugate aft...

Relay dislikes SHP2 inhibitor after Genentech leaves behind

.3 full weeks after Roche's Genentech system bowed out an SHP2 inhibitor contract, Relay Rehab has a...

Stoke's Dravet disorder med released of partial professional grip

.Stoke Rehabs' Dravet syndrome medicine has been devoid of a partial hold, clearing the way for the ...

Fierce Biotech's Gabrielle Masson provides Brutal 15 at NYSE

.Fierce Biotech Colleague Publisher Gabrielle Masson showed the 2024 course of Strong 15 champions o...